Vik Chopra
Stock Analyst at Wells Fargo
(3.35)
# 956
Out of 5,182 analysts
68
Total ratings
48.28%
Success rate
5.26%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $86 → $83 | $62.49 | +32.82% | 6 | Feb 27, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $13 → $12 | $9.33 | +28.62% | 3 | Feb 27, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $12 → $13 | $11.52 | +12.85% | 5 | Feb 27, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $98 → $104 | $90.00 | +15.56% | 12 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $76 → $87 | $73.85 | +17.81% | 4 | Feb 25, 2026 | |
| MASI Masimo | Downgrades: Equal-Weight | $190 → $180 | $178.73 | +0.71% | 11 | Feb 18, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $21 → $26 | $25.29 | +2.81% | 4 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $181 → $200 | $166.87 | +19.85% | 5 | Feb 5, 2026 | |
| CNMD CONMED | Maintains: Equal-Weight | $41 → $42 | $34.54 | +21.60% | 7 | Jan 29, 2026 | |
| ENOV Enovis | Maintains: Overweight | $41 → $42 | $22.52 | +86.50% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $14.51 | +10.27% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $11.03 | +45.06% | 2 | Oct 16, 2025 |
Solventum
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $86 → $83
Current: $62.49
Upside: +32.82%
Integra LifeSciences Holdings
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $9.33
Upside: +28.62%
DENTSPLY SIRONA
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $11.52
Upside: +12.85%
Globus Medical
Feb 26, 2026
Maintains: Overweight
Price Target: $98 → $104
Current: $90.00
Upside: +15.56%
Henry Schein
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $76 → $87
Current: $73.85
Upside: +17.81%
Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190 → $180
Current: $178.73
Upside: +0.71%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $25.29
Upside: +2.81%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181 → $200
Current: $166.87
Upside: +19.85%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41 → $42
Current: $34.54
Upside: +21.60%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $22.52
Upside: +86.50%
Nov 5, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $14.51
Upside: +10.27%
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $11.03
Upside: +45.06%